GLPBio

Viral Diseases

Research Areas

Products Related to Viral Diseases(300)

  • GC46936 structure
    GC46936Boceprevir-d9
    CAS: 1256751-11-7
    Purity: >99.00%

    An internal standard for the quantification of boceprevir

  • GC46937 structure
    GC46937Boc-Glu-OBzl
    CAS: 30924-93-7
    Purity: >98.00%

    An amino acid-containing building block

  • GC47022 structure
    GC47022Camostat-d6 (hydrochloride)
    CAS: 2930627-60-2
    Purity: >99.00%

    A neuropeptide with diverse biological activities

  • GC47128 structure
    GC47128CU-32
    CAS: 2400954-16-5
    Purity: >98.00%

    A cGAS inhibitor

  • GC47266 structure
    GC47266D-Ornithine lactam
    CAS: 88763-76-2
    Purity: >95.00%

    A building block

  • GC47295 structure
    GC47295Enviroxime
    CAS: 72301-79-2
    Purity: >95.00%

    An antiviral agent

  • GC47330 structure
    GC47330Faldaprevir-d6
    CAS: 2750534-88-2
    Purity: >99.00%

    Faldaprevir-d6은 Faldaprevir로 표시된 중수소입니다.

  • GC47391 structure
    GC47391Ganciclovir-d5
    CAS: 1189966-73-1
    Purity: >99.00%

    An internal standard for the quantification of ganciclovir

  • GC47445 structure
    GC47445Hydroxychloroquine-d4 (sulfate)
    CAS: 1854126-45-6
    Purity: >99.00%

    An internal standard for the quantification of hydroxychloroquine

  • GC47452 structure
    GC47452Imatinib-d3
    CAS: 1134803-18-1
    Purity: >99.00%

    Imatinib-d3(STI571-d3) 염산염은 Imatinib으로 표지된 중수소입니다. Imatinib(STI571)은 BCR/ABL, v-Abl, PDGFR 및 c-kit 키나제 활성을 선택적으로 억제하는 경구 생체이용 티로신 키나제 억제제입니다. 이마티닙(STI571)은 ATP 결합 부위에 가깝게 결합하여 폐쇄되거나 자가 억제된 형태로 고정하여 단백질의 효소 활성을 반경쟁적으로 억제함으로써 작동합니다. 이마티닙은 또한 SARS-CoV 및 MERS-CoV의 억제제입니다.

  • GC47453 structure
    GC47453Imiquimod-d9
    CAS: 2712126-48-0
    Purity: >99.00%

    A neuropeptide with diverse biological activities

  • GC47474 structure
    GC47474Itraconazole-d5
    CAS: 1217510-38-7
    Purity: >99.00%

    An internal standard for the quantification of itraconazole

  • GC47551 structure
    GC47551Ledipasvir-d6
    CAS: 2050041-12-6
    Purity: >99.00%

    An internal standard for the quantification of ledipasvir

  • GC47573 structure
    GC47573Lopinavir-d8
    CAS: 1322625-54-6
    Purity: >99.00%

    An internal standard for the quantification of lopinavir

  • GC47659 structure
    GC47659Methyl 3,4-Dihydroxyphenylacetate
    CAS: 25379-88-8
    Purity: >98.00%

    A polyphenol with antioxidant and antiviral activities

  • GC47707 structure
    GC47707MPro Inhibitor 11a
    CAS: 2103278-86-8
    Purity: >95.00%

    An inhibitor of SARS-CoV-2 M pro

  • GC47708 structure
    GC47708MPro Inhibitor 11b
    CAS: 2413716-71-7
    Purity: >98.00%

    MPro 억제제 11b는 IC50이 40nM인 SARS-CoV-2 3CLpro 공유 억제제입니다.

  • GC47858 structure
    GC47858Palmitelaidic Acid-d13
    CAS: 2692623-91-7
    Purity: >99.00%

    A neuropeptide with diverse biological activities

  • GC48006 structure
    GC48006PSI-7977-13C-d3
    CAS: 2070009-25-3
    Purity: >99.00%

    An internal standard for the quantification of PSI-7977

  • GC48036 structure
    GC48036Remdesivir-d4
    CAS: 2738376-82-2
    Purity: >99.00%

    A neuropeptide with diverse biological activities

  • GC48101 structure
    GC48101SSAA09E1
    CAS: 433212-75-0
    Purity: >98.00%

    A SARS-CoV entry inhibitor

  • GC48130 structure
    GC48130Taurohyocholic Acid (sodium salt)
    CAS: 117997-17-8
    Purity: >95.00%

    A taurine-conjugated form of hyocholic acid

  • GC48136 structure
    GC48136Telaprevir-d4
    Purity: >99.00%

    A neuropeptide with diverse biological activities

  • GC48143 structure
    GC48143Tenofovir-d6
    CAS: 1020719-94-1
    Purity: >99.00%

    An internal standard for the quantification of tenofovir